11 – 20 of 46
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis
(
- Contribution to journal › Article
- 2023
-
Mark
Survival in Swedish patients with systemic sclerosis : A nationwide population-based matched cohort study
(
- Contribution to journal › Article
-
Mark
High risk of stroke in ANCA-Associated vasculitis-a population-based study
(
- Contribution to journal › Article
- 2022
-
Mark
Comment on : Incidence of extra-articular manifestations in AS, PsA and undifferentiated SpA: Results from a national register-based cohort study. Reply
(
- Contribution to journal › Letter
-
Mark
Severe infections in patients with ANCA-associated vasculitis treated with rituximab
(
- Contribution to journal › Article
-
Mark
Infection is associated with increased risk of MPO- but not PR3-ANCA associated vasculitis
(
- Contribution to journal › Article
-
Mark
Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Evaluation of revised classification criteria for giant cell arteritis and its clinical phenotypes
(
- Contribution to journal › Article
- 2021
-
Mark
Comment on : Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis: Reply
(
- Contribution to journal › Letter
-
Mark
Incidence and prevalence of systemic sclerosis globally : A comprehensive systematic review and meta-analysis
(
- Contribution to journal › Scientific review